Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nancy A. Sacco"'
Autor:
Beau Bruneau, Kristin Surdam, Amy Bland, Amy Krueger, Andrew Wise, Ani Cotarlan, Asher Leviton, Elena Jouravleva, Grace Fitzgerald, Heather N. Frost, Honora F. Cutler, Joshua Buddle, Luis G. Diaz, Michele Cohen, Nancy A. Sacco, Ryan Washington, Susan Mauermann, Victor Chen, Andrea Bastek
Publikováno v:
Contemporary Clinical Trials Communications, Vol 40, Iss , Pp 101291- (2024)
Background: This Site Feasibility Task Force convened to assess the complex and burdensome process of site feasibility in clinical trials. The objective was to create mutual understanding of challenges and provide suggestions for improving collaborat
Externí odkaz:
https://doaj.org/article/d23830b9612b476b8897b8a2ef239bfc
Autor:
Roslin Russell, N. F. A. Peel, Richard Eastell, Jean-Pierre Devogelaer, C Nagant de Deuxchaisnes, A.A. Chines, Nancy A. Sacco-Gibson, D.E. Bax
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 11(4)
The aim of the study was to assess risedronate's effect on bone mineral density in postmenopausal women with rheumatoid arthritis receiving glucocorticoids. We carried out a two center, 2 year, double-masked, placebo-controlled trial with a third yea
Autor:
Nancy A. Sacco-Gibson, Rachelle Eusebio, Karen A. Pallone, Christopher Brezovic, S. C. Kelly, John D. Nesbitt, Gary A. Thompson, James H. Powefl, David Y. Mitchell
Publikováno v:
Journal of clinical pharmacology. 40(3)
Risedronate is a pyridinyl bisphosphonate approved for the treatment of Paget's disease (US-FDA) and in development for the treatment and prevention of osteoporosis. This study examined risedronate pharmacokinetics and tolerability after oral adminis
Autor:
Rachelle Eusebio, Dietrich Wenderoth, Silvano Adami, David M. Reid, Rodney A. Hughes, Roland F. J. M. Laan, Nancy A. Sacco-Gibson, Jean-Pierre Devogelaer
Publikováno v:
Journal of Bone and Mineral Research, 15, 1006-1013
Journal of Bone and Mineral Research, 15, 6, pp. 1006-1013
Journal of Bone and Mineral Research, 15, 6, pp. 1006-1013
Long-term use of high-dose corticosteroids often results in bone loss, which may lead to osteoporosis-related fractures. This was a multicenter, double-blind study in which 290 ambulatory men and women receiving high-dose oral corticosteroid therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1399ce94e49510edc411cf44a53801
http://hdl.handle.net/2066/184466
http://hdl.handle.net/2066/184466